BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
Tesla
TSLA
|
+$488M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$271M |
| 5 |
Abbott
ABT
|
+$253M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$642M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Visa
V
|
+$487M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$441M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$252M |
Sector Composition
| 1 | Technology | 18.06% |
| 2 | Financials | 12.01% |
| 3 | Consumer Discretionary | 9.98% |
| 4 | Healthcare | 8.94% |
| 5 | Communication Services | 6.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Orthofix Medical
OFIX
$589M
| $353K | ﹤0.01% |
8,802
-613
| -7% | -$24.6K |
|
2002
Harmonic Inc
HLIT
$1.13B
| $352K | ﹤0.01% |
41,329
-13,102
| -24% | -$112K |
|
2003
LendingTree
TREE
$978M
| $349K | ﹤0.01% |
1,645
-1,821
| -53% | -$386K |
|
2004
Pegasystems
PEGA
$9.93B
| $344K | ﹤0.01% |
4,936
-2,606
| -35% | -$181K |
|
2005
Choice Hotels
CHH
$5.22B
| $343K | ﹤0.01% |
2,888
-1,483
| -34% | -$176K |
|
|
CNSL
2006
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $343K | ﹤0.01% |
39,050
-2,063
| -5% | -$18.1K |
|
2007
Ambac
AMBC
$413M
| $343K | ﹤0.01% |
21,895
-2,101
| -9% | -$32.9K |
|
|
PLAN
2008
DELISTED
Anaplan, Inc.
PLAN
| $343K | ﹤0.01% |
6,432
-102,757
| -94% | -$5.48M |
|
2009
Domo
DOMO
$701M
| $343K | ﹤0.01% |
4,238
-2,954
| -41% | -$239K |
|
2010
Northfield Bancorp
NFBK
$492M
| $342K | ﹤0.01% |
20,871
-4,355
| -17% | -$71.4K |
|
2011
Dorian LPG
LPG
$1.35B
| $342K | ﹤0.01% |
24,215
+8,027
| +50% | +$113K |
|
2012
Bank of Montreal
BMO
$90.5B
| $341K | ﹤0.01% |
3,326
| – | – |
|
|
TPTX
2013
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $341K | ﹤0.01% |
4,367
-628
| -13% | -$49K |
|
2014
ProPetro Holding
PUMP
$484M
| $340K | ﹤0.01% |
37,104
-3,993
| -10% | -$36.6K |
|
|
GMRE
2015
Global Medical REIT
GMRE
$512M
| $340K | ﹤0.01% |
23,006
+2,715
| +13% | +$40.1K |
|
2016
iShares Core MSCI Emerging Markets ETF
IEMG
$106B
| $338K | ﹤0.01% |
5,043
| – | – |
|
2017
Koppers
KOP
$567M
| $337K | ﹤0.01% |
10,423
+3,378
| +48% | +$109K |
|
2018
Astrana Health
ASTH
$1.38B
| $336K | ﹤0.01% |
5,349
+2,834
| +113% | +$178K |
|
2019
OraSure Technologies
OSUR
$242M
| $336K | ﹤0.01% |
33,114
+10,454
| +46% | +$106K |
|
2020
MGP Ingredients
MGPI
$596M
| $335K | ﹤0.01% |
4,953
+1,060
| +27% | +$71.7K |
|
2021
TFS Financial
TFSL
$3.75B
| $335K | ﹤0.01% |
16,502
-100,248
| -86% | -$2.04M |
|
|
LGF.B
2022
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $334K | ﹤0.01% |
18,260
+8,886
| +95% | +$163K |
|
|
AVTA
2023
DELISTED
Avantax, Inc. Common Stock
AVTA
| $331K | ﹤0.01% |
19,131
-6,898
| -27% | -$119K |
|
2024
Enanta Pharmaceuticals
ENTA
$177M
| $330K | ﹤0.01% |
7,508
-316
| -4% | -$13.9K |
|
2025
Atara Biotherapeutics
ATRA
$85.1M
| $329K | ﹤0.01% |
847
-595
| -41% | -$231K |
|